Urinary bladder carcinogenesis in rodents bears numerous similarities to the diseases in humans. In rats, the process progresses through the morphologic stages of simple hyperplasia, papillary and nodular hyperplasia, papilloma, noninvasive, and invasive carcinoma. In mice, the pathogenesis can be similar or can follow a sequence of marked dysplasia with or without hyperplasia, leading to carcinoma in situ and ultimately to high-grade invasive carcinoma. Although the papillary and nonpapillary diseases appear to be related in rodents and in humans, they are distinct morphologically, biologically, and molecularly. Numerous classes of genotoxic chemicals have been identified as bladder carcinogens in rodents, and some of these have also been identified as carcinogenic in humans, most notably, aromatic amines, nitrosamines, and cyclophosphamide. In contrast, nongenotoxic chemicals appear to be highly specific with respect to species, strain, diet, agent, dose, and mechanism. For some, it is unclear whether the results at high doses in rodents can be extrapolated to low doses or to humans, e.g., chemicals that cause bladder cancer only at high doses related to the formation of calculi. Numerous observations in rodents can assist in identifying possible mechanisms involved for these nongenotoxic chemicals and therefore can be important for a rational evaluation of human risk.
2. Arnold LL, Anderson T, Cano M, St John M, Mattson B, Wehner J, and Cohen SM (1995). A comparison of urinary chemistry changes in male and female rats and mice treated with sodium saccharin.Toxicologist15: 201 (abstract).
3.
3. Arnold LL, Christenson R, Cano M, St John MK, Wahl BS, and Cohen SM (1998). Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats. Fundam. Appl. Toxicol. (in press).
4.
4. Auerbach O and Garfinkel L (1989). Histologic changes in the urinary bladder in relation to cigarette smoking and use of artificial sweeteners.Cancer64: 983–987.
5.
5. Becci PJ, Thompson HJ, Strum JM, Brown DD, Sporn MB, and Moon RC (1981). N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 × DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.Cancer Res.41: 927–932.
6.
6. Burin GJ, Gibb HJ, and Hill RN (1995). Human bladder cancer: Evidence for a potential irritation-induced mechanism.Food Client. Toxicol.33: 785–795.
7.
7. Clayson DB and Cooper EH (1970). Cancer of the urinary tract.Adv. Cancer Res.13: 271–381.
8.
8. Clayson DB, Fishbein L, and Cohen SM (1995). Effects of stones and other physical factors on the induction of rodent bladder cancer.Food Chem. Toxicol.33: 771–784.
9.
9. Cohen SM (1983). Pathology of experimental bladder cancer in rodents. In: The Pathology of Bladder Cancer, Vol. II, SM Cohen and GT Bryan (eds). CRC Press, Boca Raton, Florida, pp. 1–40.
10.
10. Cohen SM (1995). Role of urinary physiology and chemistry in bladder carcinogenesis.Food Chem. Toxicol.33: 715–730.
11.
11. Cohen SM (1997). The role of cell proliferation in the etiology of neoplasia. In: Chemical Carcinogens and Anticarcinogens, Vol. 12 of Comprehensive Toxciology, -IG Sipes, AJ Gandolfi, and CA McQuee (eds). Pergamon (Elsevier), Amsterdam, pp. 401–424.
12.
12. Cohen SM, Cano M, Garland EM, St John M, and Arnold L (1995). Urinary and urothelial effects of sodium salts in male rats.Carcinogenesis16: 343–348.
13.
13. Cohen SM, Cano M, Johnson LS, St John MK, Asamoto M, Garland EM, Thyssen JH, Sangha GK, and Van Goethem DL (1994). Mitogenic effects of propoxur on male rat bladder urothelium.Carcinogenesis15: 2593–2597.
14.
14. Cohen SM and Ellwein LB (1990). Cell proliferation in carcinogenesis.Science249: 1007–1011.
15.
15. Cohen SM and Ellwein LB (1990). Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis. Biological modeling of the ED01 study.Toxicol. Appl. Pharmacol.104: 79–93.
16.
16. Cohen SM and Ellwein LB (1991). Genetic errors, cell proliferation, and carcinogenesis.Cancer Res.51: 6493–6505.
17.
17. Cohen SM and Ellwein LB (1992). Risk assessment based on high-dose animal exposure experiments.Chem. Res. Toxicol.51: 6493–6505.
18.
18. Cohen SM and Ellwein LB (1995). Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors.Toxicol. Pathol.23: 136–142.
19.
19. Cohen SM and Johansson SL (1992). Epidemiology and etiology of bladder cancer.Urol. Clin. North Am.19: 421–428.
20.
20. DeSesso JM (1995). Anatomical relationships of urinary bladders compared: Their potential role in the development of bladder tumours in humans and rats.Food Chem. Toxicol.33: 705–714.
21.
21. Elcock M and Morgan RW (1993). Update on artificial sweeteners and bladder cancer.Regul. Toxicol. Pharmacol.17: 35–43.
22.
22. Ellwein LB and Cohen SM (1990). The health risks of saccharin revisited.Crit. Rev. Toxicol.20: 311–326.
23.
23. Emerick RJ, Kugel EE, and Wallace V (1963). V. Urinary excretion of silica and the production of siliceous urinary calculi in rats.Am. J. Vet. Res.24: 610–613.
24.
24. Friedell GH, Nagy GK, and Cohen SM (1983). Pathology of human bladder cancer and related lesions. In: The Pathology of Bladder Cancer, Vol. I, SM Cohen and GT Bryan (eds). CRC Press, Boca Raton, Florida, pp. 11–42.
25.
25. Fukushima S, Cohen SM, Arai M, Jacobs JB, and Friedell GH (1981). Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder.Am. J. Pathol.102: 373–380.
26.
26. Garland EM, St John M, Asamoto M, Eklund SH, Mattson BJ, Johnson LS, Cano M, and Cohen SM (1994). A comparison of the effects of sodium saccharin in NBR rats and in intact and castrated male F344 rats.Cancer Lett.78: 99–107.
27.
27. Hard GC (1995). Species comparison of the content and composition of urinary proteins.Food Chem. Toxicol.33: 731–746.
28.
28. Hirage K and Fujii T (1984). Induction of tumours of the urinary bladder in F344 rats by dietary administration of o-phenylphenol.Food Chem. Toxicol.22: 865–870.
29.
29. Jackson CD, Frith CH, West RW, and Stanley JW (1979). Effects of 4-ethylsulfonylnaphthalene-1-sulfonamide, acetazolamide, and oxamide on the mouse urinary tract. In: Toxicology and Occupational Medicine.North Holland, New York, Elsevier, p. 233.
30.
30. Jull JW (1979). The effect of time oh the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder.Cancer Lett.6: 21–25.
31.
31. Kadlubar FF, Miller JA, and Miller EC (1977). N-glucuronidation and nucleic acid binding of N-hydroxyarylamines in relation to urinary bladder carcinogenesis.Cancer Res.37: 805–814.
32.
32. King C, Want C, Gorelick N, and Frederick C (1995). Genotoxicity in the rodent urinary bladder.Food Chem. Toxicol.33: 757–769.
33.
33. Klopman G and Rosenkranz HS (1994). Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.Mutat. Res.305: 33–46.
34.
34. Murasaki G and Cohen SM (1983). Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder.Carcinogenesis4: 97–99.
35.
35. Neumann DA and Olin SS (1995). Urinary bladder carcinogenesis: A working group approach to risk assessment.Food Chem. Toxicol.33: 701–704.
36.
36. Ogavva K, Uzvolgyi E, St John MS, deOliveria ML, Arnold L, and Cohen S (1998). Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice. Mol. Carcinogenesis (in press).
37.
37. Okamura T, Garland EM, Johnson LS, Cano M, Johansson S, and Cohen SM (1992). Acute urinary tract toxicity of tetraethylorthosilicate (TES) in rats.Fundam. Appl. Toxicol.18: 425–441.
38.
38. Oyasu R (1995). Epithelial tumours of the lower urinary tract in humans and rodents.Food Chem. Toxicol.33: 747–755.
39.
39. Pamukcu AM (1983). Tumors of the urinary bladder in domesticated animals. In: The Pathology of Bladder Cancer, Vol. I, SM Cohen and GT Bryan (eds). CRC Press, Boca Raton, Florida, pp. 153–185.
40.
40. Poirier MC, Fullerton NG, Kinouchi T, Smith BA, and Beland FA (1991). Comparison between DNA adduct formation and tumori-genesis in livers and bladders of mice chronically fed 2-acetylam-inofluorene.Carcinogenesis12: 895–900.
41.
41. Rodent Bladder Carcinogenesis Working Group.Urinary bladder carcinogenesis: Implications for risk assessment. Food Chem. Toxicol.33: 797–802.
42.
42. Sakata T, Masui T, St John M, and Cohen SM (1988). Uracil-induced calculi and proliferative lesions of the mouse urinary bladder.Carcinogenesis9: 1271–1276.
43.
43. Cohen SM, Arnold LL, St. John MK, Cano M, Smith RA, Sangha G, and Christenson R (1997). Urothelial proliferation induced by high doses of o-phenylphenol (OPP) in male rats.Proc. Am. Assoc. Cancer Res.38: 465 (abstract).
44.
44. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schumette C, Yang AS, Cote R, Dubeau L, Nichols PW, Nermann GG, Steven K, Horn T, Skinner DG, and Jones PA (1994). Two molecular pathways to transitional cell carcinoma of the bladder.Cancer Res.54: 784–788.
45.
45. Staff JA and Mehlman MA (1980). Innovations in cancer risk assessment (ED01 study).J. Environ. Pathol. Toxicol.3: 1–246.
46.
46. Takayama S, Sieber SM, Adamson RH, Thorgeirsson UP, Dalgard DW, Arnold LL, Cano M, Eklund S, and Cohen SM (1997). Lack of effect of sodium saccharin on monkey urine and urinary bladder in a long-term study. J. Natl. Cancer Inst. (in press).
47.
47. Uwagawa S, Saito K, Okuno Y, Kawasaki H, Yoshitake A, Yamada H, and Fukushima S (1994). Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-reiter (NBR) male rats.Toxicol. Appl. Pharmacol.127: 182–186.
48.
48. Wanibuchi H, Hori T, Chen H, Yoshida K, Yamamoto S, Endo G, and Fukushima S (1996). Promoting effect of dimethylarsinic acid on rat bladder and liver carcinogenesis.Carcinogenesis37: 160.
49.
49. Yamazoe Y, Zenser TV, Miller DW, and Kadlubar FF (1988). Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine.Carcinogenesis9: 1635–1641.
